What is the ICD-10 (International Classification of Diseases, 10th Revision) code for Chondrosarcoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The ICD-10 code for chondrosarcoma is not explicitly stated in the provided evidence, however, according to the 2002 WHO classification of malignant bone tumors, the code for chondrosarcoma is 9220/3.

Chondrosarcoma ICD-10 Code

When looking at the provided evidence from the study published in the Annals of Oncology 1, we can see that the code 9220/3 is used for central, primary, and secondary chondrosarcoma.

  • The code 9221/3 is used for peripheral chondrosarcoma.
  • It's essential to note that the ICD-10 code for chondrosarcoma may vary depending on the specific location and type of the tumor.
  • The provided evidence does not give a direct ICD-10 code for chondrosarcoma, but based on the 2002 WHO classification, we can determine that the code 9220/3 is the most relevant one.

Importance of Accurate Coding

Accurate coding of chondrosarcoma is crucial for medical documentation, billing purposes, and healthcare statistics.

  • The specific location of the chondrosarcoma should be determined from the patient's diagnostic imaging, pathology reports, and clinical documentation.
  • Proper coding ensures appropriate treatment planning and facilitates accurate healthcare statistics and research.

Limitations of the Evidence

The provided evidence is from a study published in 2012, and it may not reflect the most recent updates in the ICD-10 coding system.

  • However, based on the available evidence, the code 9220/3 is the most relevant one for chondrosarcoma.

From the Research

Chondrosarcoma ICD10 Code

  • The ICD10 code for chondrosarcoma is not explicitly mentioned in the provided studies 2, 3, 4, 5, 6.
  • However, it is worth noting that chondrosarcomas can be classified into various forms according to the presence or absence of a precursor lesion, location, and histological subtype 2.
  • The World Health Organization (WHO) Classification of Tumors of Soft Tissue and Bone categorizes chondrosarcomas into eight subtypes, including central conventional, secondary peripheral, periosteal, dedifferentiated, mesenchymal, and clear cell chondrosarcoma 2.
  • Chondrosarcomas are the second most common primary malignancy of bone, and clinicians must determine the grade of the tumor and the likelihood of metastasis 3.
  • The standard treatment of high-grade conventional chondrosarcoma is complete surgical resection with wide margin, while low-grade lesions may be amenable to curettage plus or minus adjuvant local treatment 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Chondrosarcoma of bone.

Cancer treatment and research, 2014

Research

Chondrosarcoma.

The Journal of the American Academy of Orthopaedic Surgeons, 2021

Research

Chondrosarcoma: A Clinical Review.

Journal of clinical medicine, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.